Vista Pharmaceuticals Ltd Stock Analysis

BSE: 524711 | NSE: | Pharmaceuticals & Drugs | Small Cap

BSE Share Price 31-Mar-2023 18:02
8.36 0.35 (4.37%)

DeciZen - Make an Informed Decision on Vista Pharma

M-Cap below 100cr DeciZen not available

Vista Pharma Price Chart

P/E Ratio ( SA) :
Market Cap :
31.4 Cr.
52-wk low :
52-wk high :
Bole Toh?

1. Is Vista Pharmaceuticals Ltd a good quality company?

Past 10 year’s financial track record analysis by Moneyworks4me indicates that Vista Pharmaceuticals Ltd is a below average quality company.

2. Is Vista Pharmaceuticals Ltd undervalued or overvalued?

The key valuation ratios of Vista Pharmaceuticals Ltd's currently when compared to its past seem to suggest it is in the Overvalued zone.

3. Is Vista Pharmaceuticals Ltd a good buy now?

The Price Trend analysis by MoneyWorks4Me indicates it is Weak which suggest that the price of Vista Pharmaceuticals Ltd is likely to Fall in the short term. However, please check the rating on Quality and Valuation before investing.

10 Year X-Ray of Vista Pharma:

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end
Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.

Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.
Vista Pharmaceuticals Ltd has not performed well majority of the past ten years indicating its past ten year financial track record is not good

Value Creation

Value Creation Index Colour Code Guide

ROCE % 1%5.3%14.5%8.4%7.9%8.8%2.6%-5.9%-2.1%-0.4%-
Value Creation Index -0.9-0.60.0-0.4-0.4-0.4-0.8-1.4-1.2-1.0-

Growth Parameters

Growth Parameters Colour Code Guide

Sales 7.58.313.815.424.228.931.
YoY Gr. Rt. %-11.1%65.7%11.9%57.2%19.6%7.4%-26.8%-94.4%-69.3%-
YoY Gr. Rt. %-500%83.3%218.2%34.3%48.9%-100%NANANA-
BVPS (₹)
Adj Net Profit
Cash Flow from Ops. 0.2-0.1-3.5-2.52.6-
Debt/CF from Ops. 00-1.1-3.24.4-2.43.419.3-1.6-12.6-


CAGR Colour Code Guide

9 Years 5 Years 3 Years 1 Years
Sales -28%-56.2%-76.8%-69.3%
Adj EPS -241.7%-186.7%NANA
BVPS 5.99.1-4.28
Share Price 8.1% -25.6% 18.4% -11.1%

Key Financial Parameters

Performance Ratio Colour Code Guide

Return on Equity % 0.95.314.5898.40-11.6-6.4-2.41
Op. Profit Mgn % 10.914.720.317.712.618.54-21.1-136.6-306.80
Net Profit Mgn % 1.15.610.35.65.270-16.6-158.6-210.80
Debt to Equity
Working Cap Days 83901893322702902873516,40821,7380
Cash Conv. Cycle -82-119-179552591532493,97710,0120

Recent Performance Summary

Return on Equity has increased versus last 3 years average to 1.00%

Sales growth has been subdued in last 3 years -76.76%

Net Profit has been subdued in last 3 years 0.00%

Sales growth is not so good in last 4 quarters at -75.00%

Latest Financials - Vista Pharmaceuticals Ltd.

Standalone Consolidated
TTM EPS (₹) 0.1 -
TTM Sales (₹ Cr.) 0 -
BVPS (₹.) 9.1 -
Reserves (₹ Cr.) 27 -
P/BV 0.92 -
PE 98.12 -
From the Market
52 Week Low / High (₹) 6.51 / 14.41
All Time Low / High (₹) 0.08 / 56.15
Market Cap (₹ Cr.) 31.4
Equity (₹ Cr.) 7.5
Face Value (₹) 2
Industry PE 36.2

Management X-Ray of Vista Pharma :

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged *
* Pledged shares as % of Promoter's holding (%)

Event Update

Login/Register to view analysis.

Analyst's Notes

Key Ratios of Vista Pharma

Adj EPS (Rs.)
Sales (Cr.)
ROE (%)
ROCE (%)


Vista Pharmaceuticals Ltd FAQs

Company share prices are keep on changing according to the market conditions. The closing price of Vista Pharma on 31-Mar-2023 18:02 is : 8.36.
Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 31-Mar-2023 18:02 the market cap of Vista Pharma stood at ₹ 31.40.
The latest PE ratio of Vista Pharma as of 31-Mar-2023 18:02 is 98.12.
The latest PB ratio of Vista Pharma as of 31-Mar-2023 18:02 is 0.92
The 52-week high of Vista Pharma is ₹ 14.41 and the 52-week low is ₹ 6.51.
The TTM revenue is Trailing Twelve Months sales. The TTM revenue / sales of Vista Pharma is ₹ 0.00 ( Cr.) .

About Vista Pharmaceuticals Ltd

Vista Pharmaceuticals Limited was incorporated on January 25,1991 under the Companies Act of 1956 with the Registrar of Companies Andhra Pradesh & has obtained Certificate of Commencement of Business on February 7, 1991. Vista Pharmaceuticals was incorporated by Dr. Dhananjaya Alli & his associates. The capital was subscribed by Vista Pharmaceuticals Inc., an Overseas Corporate Body promoted by them as a per the laws of State of New Jersy, United States of America.

The Company was in process of setting up a 100% EOU for manufcacture of drug formulations with an installed capacity of 400 million tablets & 200 million capsules per annum.

Vista, the largest division of Torrent Pharmaceuticals Ltd, offers a range of products mainly in the therapeutic areas of gastrointestinal, pain management and anti-infective, catering to common ailments. This division is a primary contributor to the domestic sales of Torrent Pharmaceuticals Ltd.

Read More Read Less
You have 2 views remaining as a Guest User. To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login | Register Now